Search results
Results from the WOW.Com Content Network
The "Interventional Study" is set both in Havana, [69] Cuba's capital and Santiago de Cuba, Cuba's second most populous city [70] [71] and in other provinces. [72] On May 6, 2021, the Finlay Institute of Vaccines announced on social media that the following adverse events have been observed: injection site pain (20%), inflammation at the ...
The COVID-19 pandemic in Cuba was a part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus was confirmed to have spread to Cuba on 11 March 2020 when three Italian tourists tested positive for the virus.
Abdala, technical name CIGB-66, is a COVID-19 vaccine developed by the Center for Genetic Engineering and Biotechnology in Cuba. [2] This candidate, named after a patriotic drama by Cuban independence hero José Martí , is a protein subunit vaccine containing COVID-derived proteins that trigger an immune response. [ 3 ]
A Cuban passport. Visa requirements for Cuban citizens are administrative entry restrictions by the authorities of other states placed on citizens of Cuba.. As of June 15, 2024, Cuban citizens had visa-free or visa on arrival access to 62 countries and territories, ranking the Cuban passport 80th in the world according to the Henley Passport Index.
For premium support please call: 800-290-4726 more ways to reach us
A brutal crackdown initially led to the arrests of more than 1,000 people. Many faced prison sentences of up to 30 years. ... In Cuba, Havana residents welcomed the news about Biden's actions.
Rubio said the Trump administration would re-create the "Cuba Restricted List," which prohibits certain transactions with companies under the control of, or acting for or on behalf of, the ...
On 20 August 2021, Cuba approved Soberana Plus as a booster after two doses of Soberana 02. [13] On 23 September, Cuba approved Soberana Plus for COVID-19 survivors over 19 years old. On 7 December, the authorization was expanded to include COVID-19 survivors from 2 to 18 years old.